Kent D Heyborne

Years Active: 2022-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Brenna L Hughes, Rebecca G Clifton, Dwight J Rouse, George R Saade, Mara J Dinsmoor, Uma M Reddy, Robert Pass, Donna Allard, Gail Mallett, Cora MacPherson, Ronald Wapner, Torri Metz, William H Goodnight, Alan T N Tita, Maged M Costantine, Geeta K Swamy, Kent D Heyborne, Edward K Chien, Suneet P Chauhan, Yasser Y El-Sayed, Brian M Casey, Samuel Parry, Hyagriv N Simhan, Peter G Napolitano, George A Macones, null null, null null
Randomized Trial of Hyperimmune Globulin for Congenital CMV Infection - 2-Year Outcomes. The New England journal of medicine 389 (19) (2023)
Julja Burchard, Glenn R Markenson, George R Saade, Louise C Laurent, Kent D Heyborne, Dean V Coonrod, Corina N Schoen, Jason K Baxter, David M Haas, Sherri A Longo, Scott A Sullivan, Sarahn M Wheeler, Leonardo M Pereira, Kim A Boggess, Angela F Hawk, Amy H Crockett, Ryan Treacy, Angela C Fox, Ashoka D Polpitiya, Tracey C Fleischer, Thomas J Garite, J Jay Boniface, John A F Zupancic, Gregory C Critchfield, Paul E Kearney
Clinical and economic evaluation of a proteomic biomarker preterm birth risk predictor: cost-effectiveness modeling of prenatal interventions applied to predicted higher-risk pregnancies within a large and diverse cohort. Journal of medical economics 25 (1) (2022)

Kent D Heyborne.css-eqlu8i{font-size:small;padding-left:4px;}